The Role of HER3 Expression in Advanced Solid Tumors - a podcast by ReachMD

CME credits: 0.50

Valid until: 15-12-2022

Claim your CME credit at https://reachmd.com/programs/cme/the-role-of-her3-expression-in-advanced-solid-tumors/12956/

HER3 is the new marker on the block, but is it diagnostic, predictive, or prognostic? Hear from the experts, Drs. Lauren Ritterhouse, Pasi Jänne, and Kanwal Raghav, as they explore the role of HER3 in oncogenesis and resistance to EGFR TKIs. Find out how we can now target HER3 signaling in metastatic solid tumors through the use of emerging HER3-targeted therapies along with novel and exciting antibody-drug conjugate studies and strategies.

Further episodes of ReachMD CME

Further podcasts by ReachMD

Website of ReachMD